Molecular analysis of anaplastic oligodendroglial tumors in a prospective randomized study: A report from EORTC study 26951. - sprookjes - yvandenbroek - TriplyDB

Molecular analysis of anaplastic oligodendroglial tumors in a prospective randomized study: A report from EORTC study 26951.

Molecular analysis of anaplastic oligodendroglial tumors in a prospective randomized study: A report from EORTC study 26951.

http://www.wikidata.org/entity/Q33410196

about

Adjuvant treatment of anaplastic oligodendrogliomas and oligoastrocytomas MGMT promoter methylation is prognostic but not predictive for outcome to adjuvant PCV chemotherapy in anaplastic oligodendroglial tumors: a report from EORTC Brain Tumor Group Study 26951.Interobserver variation of the histopathological diagnosis in clinical trials on glioma: a clinician's perspective First-line temozolomide chemotherapy in progressive low-grade astrocytomas after radiotherapy: molecular characteristics in relation to response.1p/19q testing has no significance in the workup of glioblastomas.Oligodendroglial neoplasms with ganglioglioma-like maturation: a diagnostic pitfall.Medical therapy of gliomas.Intrinsic molecular subtypes of glioma are prognostic and predict benefit from adjuvant procarbazine, lomustine, and vincristine chemotherapy in combination with other prognostic factors in anaplastic oligodendroglial brain tumors: a report from EOR Molecular pathology in adult gliomas: diagnostic, prognostic, and predictive markers Genomic aberrations associated with outcome in anaplastic oligodendroglial tumors treated within the EORTC phase III trial 26951 EGFR expression stratifies oligodendroglioma behavior.Molecular prognostic factors of anaplastic oligodendroglial tumors and its relationship: a single institutional review of 77 patients from China.The importance of 10q status in an outcomes-based comparison between 1p/19q fluorescence in situ hybridization and polymerase chain reaction-based microsatellite loss of heterozygosity analysis of oligodendrogliomas.Glioblastoma with an oligodendroglioma component: distinct clinical behavior, genetic alterations, and outcome Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial.Chromosomal Aberrations in Canine Gliomas Define Candidate Genes and Common Pathways in Dogs and Humans.Efficacy and patient-reported outcomes with dose-intense temozolomide in patients with newly diagnosed pure and mixed anaplastic oligodendroglioma: a phase II multicenter study.Molecular diagnostics: techniques and recommendations for 1p/19q assessment.Prognostic value of epidermal growth factor receptor amplification and EGFRvIII in glioblastoma: meta-analysis.Management and treatment recommendations for World Health Organization Grade III and IV gliomas.Alpha-internexin expression predicts outcome in anaplastic oligodendroglial tumors and may positively impact the efficacy of chemotherapy: European organization for research and treatment of cancer trial 26951.Something old and something new about molecular diagnostics in gliomas.Hypoxia-inducible factor-1-regulated protein expression and oligodendroglioma patient outcome: comparison with established biomarkers and preoperative UCSF low-grade scoring system.Regional specificity of 1p/19q co-deletion combined with radiological features for predicting the survival outcomes of anaplastic oligodendroglial tumor patients.Prognostic value of Ki67 index in anaplastic oligodendroglial tumours--a translational study of the European Organization for Research and Treatment of Cancer Brain Tumor Group.Polymorphous oligodendroglioma of Zülch revisited: a genetically heterogeneous group of anaplastic gliomas including tumors of bona fide oligodendroglial differentiation.Oligodendrogliomas: a short history of clinical developments.Tumor Necrosis Factor-Alpha (TNF-α-308 G>A) Polymorphism in High-grade Gliomas.

P2860

Q24194645-FA3C8594-8383-4FCA-8857-595A2661B1EB Q27851529-12E6FAA5-1B9E-484F-971D-4B94A86E2849 Q33636469-62A70C1C-6C6C-4848-A0B0-3C1A14845A1A Q33777877-D582078A-7F2E-42ED-9097-912F9B8D3643 Q33893445-7E63CD59-9094-4F28-8AE2-523B9C5A1C84 Q33942865-DB68EA7A-5272-41FA-9ADD-1C2AEBF576AC Q34218761-8F384F45-94A1-4591-954D-C8B2564E4235 Q34523475-4A1F29B3-F500-4ED2-A544-D5003BE8D659 Q34815207-B877C50E-5981-470B-BCA0-156FBEC861E5 Q34990522-F7014335-69EB-4B65-B0F3-135CA6A74D42 Q35235702-916FF9E4-C03A-4FA8-8FA2-89F2AD8E8220 Q35633835-CC6F926B-0704-4A18-8527-A306E40C3AD3 Q35634042-0CB8C4AA-FD25-42F6-B637-322A676E6F36 Q35845223-1E1CFE7F-468B-43F2-839B-7DEDD3099497 Q36618241-44468C2A-15AB-422F-9E02-ADE222F51AB6 Q37019743-63E37D41-75CF-4089-9D8D-8E458FD1E1DE Q38298229-527ADFD3-3D6E-4106-BB90-0556EA30FF2D Q38627124-F4565FB5-2E8F-44F7-BFB2-3021F2FFEA42 Q41110170-C0BF3DCF-3A68-4513-A8A3-4C7E37C29AB7 Q41706326-71E201A9-E1FF-4261-8705-2CEE013564C2 Q42756714-FBFD6F2C-0900-46D8-803C-92DBBF195D47 Q43238974-B6B16E34-43B9-4037-A087-4BF29C72BFA0 Q43619655-B654075A-2983-4C9F-99E3-E9DD255356DE Q47325891-6CFD5BDE-559C-4FA0-A9A9-73CF3F67276A Q48659691-CA5268CE-87D2-43AB-8798-D966355BBC84 Q50664620-5D06E8AF-BC99-4AE7-8C02-9708F443D93E Q52146818-9F4EB865-13CD-42A4-A651-5749BA86EC19 Q55024234-A21A5BBE-BD73-469D-AC9F-A88090E5B90D

P2860

Molecular analysis of anaplastic oligodendroglial tumors in a prospective randomized study: A report from EORTC study 26951.

http://www.wikidata.org/entity/Q33410196

description

2009 nî lūn-bûn

@nan

2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Molecular analysis of anaplast ...... report from EORTC study 26951.

@ast

Molecular analysis of anaplast ...... report from EORTC study 26951.

@en

type

label

Molecular analysis of anaplast ...... report from EORTC study 26951.

@ast

Molecular analysis of anaplast ...... report from EORTC study 26951.

@en

prefLabel

Molecular analysis of anaplast ...... report from EORTC study 26951.

@ast

Molecular analysis of anaplast ...... report from EORTC study 26951.

@en

P1433

Q33410196-37A992BA-6763-4F3A-8762-4F60DEDCEE7E

P1476

Q33410196-62416C0A-20C4-4273-AEC7-4B476ACBF439

P2093

Q33410196-04DD4A46-D40E-4124-96E8-AD9B578FD295

Q33410196-1624C029-5D46-4519-BF7C-8423DC16DE50

Q33410196-1B56D8B3-09DE-49D3-A36E-B8F5A2C9C958

Q33410196-2E5CFD62-A021-4F14-A26B-E411AD99E016

Q33410196-4B22FF88-03BE-42DC-B790-3BF2435A52D0

Q33410196-745AAE6B-9202-48EF-B6F9-F76FBD1C4D19

Q33410196-B13995E5-4D77-41A4-BF4E-AEEE5579F1AF

Q33410196-C4DD5B07-9D02-45DE-A5B8-B6CE5D71671A

Q33410196-CCEEAF3D-E789-41C8-BD67-DC5EA4EBE74B

Q33410196-CE4053DA-6A1A-4644-818E-4140449FDBCD

P2860

Q33410196-06150356-2D42-43A7-8D6A-17443B2B5810

Q33410196-0BF37585-FE15-4093-8BF2-8600C6C2D711

Q33410196-2BA80A7D-F4E4-4F0B-923B-3822F1357E36

Q33410196-32A552B8-10D8-499C-A2B9-536D9F8BBC49

Q33410196-36F7C205-B019-47B4-8231-34B61AAEA1D6

Q33410196-3DBE968B-68E9-4EF1-8208-5EBBC0AE6CF9

Q33410196-3F3F4835-0683-4277-AE5D-39F91F660381

Q33410196-54FC8DE3-5630-4A14-B9F8-B3E3A9E6F8F4

Q33410196-58ED24BA-E9D5-4CBB-A1ED-A88D93D74DCE

Q33410196-5E758916-EE7C-4D5E-8E40-BD70F80B995F

P304

Q33410196-1C827D54-0E2A-4030-841F-9B264E653C72

P31

Q33410196-341A8228-94DF-4480-9430-329F9FE7FA95

P356

Q33410196-B638A745-9F97-4229-A8AD-13323CA45091

P433

Q33410196-59A93045-C70D-4396-BB9D-0FB212F9AF06

P478

Q33410196-F27C7BE9-C342-4C93-9EFB-65A694E23990

P50

Q33410196-6EC03B3B-AAFF-4F18-94E1-622832B34C29

Q33410196-7DBA234D-065B-4F3D-92DC-2F454539FBA7

Q33410196-D329A745-20F0-4F0E-9BD5-43A906A7CA20

P577

Q33410196-38E7A32F-361F-4E1F-925B-731833058AA7

P5875

Q33410196-A64E7749-6D19-42E4-BDD1-B36186FF11DA

P698

Q33410196-20824105-D280-47FA-8EA9-6E451104ADFA

P921

Q33410196-2E65912C-B203-41B0-BE08-8E52FCF705A0

P932

Q33410196-878CB104-5617-43AE-B211-1ADBF44C0965

P356

15228517-2009-011

P1433

P1476

Molecular analysis of anaplast ...... report from EORTC study 26951

@en

P2093

Ahmed Ibdaih

http://www.w3.org/2001/XMLSchema#string

Anouk Allgeier

http://www.w3.org/2001/XMLSchema#string

Charles J Vecht

http://www.w3.org/2001/XMLSchema#string

Denis Lacombe

http://www.w3.org/2001/XMLSchema#string

Fanny Vandenbos

http://www.w3.org/2001/XMLSchema#string

Jacolien E C Bromberg

http://www.w3.org/2001/XMLSchema#string

Johan M Kros

http://www.w3.org/2001/XMLSchema#string

Johannes L Teepen

http://www.w3.org/2001/XMLSchema#string

Karima Mokhtari

http://www.w3.org/2001/XMLSchema#string

László Sipos

http://www.w3.org/2001/XMLSchema#string

P2860

MGMT gene silencing and benefit from temozolomide in glioblastoma.

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Chromosomal anomalies in oligodendroglial tumors are correlated with clinical features.

Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial.

Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Ca

1p/19q loss within oligodendroglioma is predictive for response to first line temozolomide but not to salvage treatment.

Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group.

A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma.

Genetic signature of oligoastrocytomas correlates with tumor location and denotes distinct molecular subsets

Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p

P304

737-746

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1215/15228517-2009-011

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

Mathilde Kouwenhoven

Alba A. Brandes

Martin J van den Bent

P577

2009-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24022728

http://www.w3.org/2001/XMLSchema#string

P698

19224764

http://www.w3.org/2001/XMLSchema#string

P921

oligodendrocyte

P932

2802394

http://www.w3.org/2001/XMLSchema#string